The Food and Drug Administration has rejected an application to expand the use of rheumatoid arthritis treatment Rituxan for patients with earlier stages of the disease, biotech drug developers Genentech Inc. and Biogen Idec said Saturday.
FDA nixes wider use of rheumatoid arthritis drugCourtesy Newsvine - business Sat, 10/17/2009 - 09:52
The Food and Drug Administration has rejected an application to expand the use of rheumatoid arthritis treatment Rituxan for patients with earlier stages of the disease, biotech drug developers Genentech Inc. and Biogen Idec said Saturday. Related itemsFDA clears Genentech drug for kidney cancer
Mead Johnson Says Its Tests Show Enfamil Baby Formula...
After-Hours Movers 10/19: (NEOP) (RVBD) (SCSS) (CBST)...
Panasonic Dect 6.0 Expandable Silver Digital Cordless...
Wireless Headset W Adapter for Cordless Telephones
|
Popular by tags WeekMonth |
Post new comment